Diagnosis of NKH typically involves a combination of clinical evaluation and laboratory testing. Elevated glycine levels in the blood and cerebrospinal fluid are indicative of the disorder. Genetic testing can confirm mutations in the genes associated with the glycine cleavage system. An MRI may also be performed to identify any structural abnormalities in the brain.
